Major Estimate Revision • Jun 08
Consensus EPS estimates increase by 13% The consensus outlook for earnings per share (EPS) in fiscal year 2026 has improved. 2026 revenue forecast increased from ₩322.0m to ₩328.0m. EPS estimate increased from ₩920 to ₩1,040 per share. Net income forecast to grow 8.5% next year vs 38% growth forecast for Personal Products industry in South Korea. Consensus price target down from ₩13,000 to ₩12,000. Share price fell 7.8% to ₩10,060 over the past week. Price Target Changed • May 29
Price target decreased by 7.1% to ₩13,000 Down from ₩14,000, the current price target is an average from 2 analysts. New target price is 13% above last closing price of ₩11,540. Stock is down 27% over the past year. The company is forecast to post earnings per share of ₩920 for next year compared to ₩774 last year. Anuncio • May 07
CLIO Cosmetics Co.,Ltd to Report Q1, 2026 Results on May 11, 2026 CLIO Cosmetics Co.,Ltd announced that they will report Q1, 2026 results on May 11, 2026 Anuncio • Mar 14
CLIO Cosmetics Co.,Ltd, Annual General Meeting, Mar 31, 2026 CLIO Cosmetics Co.,Ltd, Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 66, wangsimni-ro, seongdong-gu, seoul South Korea Valuation Update With 7 Day Price Move • Mar 04
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₩11,170, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total loss to shareholders of 38% over the past three years. Anuncio • Feb 13
CLIO Cosmetics Co.,Ltd to Report Fiscal Year 2025 Results on Feb 13, 2026 CLIO Cosmetics Co.,Ltd announced that they will report fiscal year 2025 results on Feb 13, 2026 Anuncio • Jan 07
CLIO Cosmetics Co.,Ltd announced that it has received KRW 8.42292238 billion in funding from NH Investment & Securities Co., Ltd., KB Securities Co., Ltd., Mirae Asset Securities Co., Ltd., Samsung Securities Co.,Ltd., Synergy IB Investment Co., Ltd., Synergy-Premier Mezzanine Blind No. 1 New Technology Business Investment Fund and other investors On January 7, 2026, CLIO Cosmetics Co.,Ltd closed the transaction. Anuncio • Aug 09
CLIO Cosmetics Co.,Ltd to Report First Half, 2025 Results on Aug 13, 2025 CLIO Cosmetics Co.,Ltd announced that they will report first half, 2025 results on Aug 13, 2025 New Risk • May 23
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.0% Last year net profit margin: 9.2% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (6.0% net profit margin). Major Estimate Revision • May 17
Consensus EPS estimates fall by 19% The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩384.0m to ₩359.0m. EPS estimate also fell from ₩1,826 per share to ₩1,486 per share. Net income forecast to shrink 4.9% next year vs 34% growth forecast for Personal Products industry in South Korea . Consensus price target down from ₩28,750 to ₩23,800. Share price fell 19% to ₩15,450 over the past week. Valuation Update With 7 Day Price Move • May 15
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₩16,080, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 13x in the Personal Products industry in South Korea. Total loss to shareholders of 1.6% over the past three years. Anuncio • Mar 12
CLIO Cosmetics Co.,Ltd, Annual General Meeting, Mar 28, 2025 CLIO Cosmetics Co.,Ltd, Annual General Meeting, Mar 28, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 66, wangsimni-ro, seongdong-gu, seoul South Korea Valuation Update With 7 Day Price Move • Mar 11
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ₩21,100, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 11x in the Personal Products industry in South Korea. Total returns to shareholders of 1.6% over the past three years. Major Estimate Revision • Feb 26
Consensus EPS estimates fall by 16% The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩417.1m to ₩384.0m. EPS estimate also fell from ₩2,165 per share to ₩1,826 per share. Net income forecast to shrink 0.2% next year vs 32% growth forecast for Personal Products industry in South Korea . Consensus price target down from ₩34,250 to ₩28,750. Share price fell 9.8% to ₩17,740 over the past week. Price Target Changed • Nov 13
Price target decreased by 13% to ₩39,286 Down from ₩45,143, the current price target is an average from 7 analysts. New target price is 125% above last closing price of ₩17,480. Stock is down 43% over the past year. The company is forecast to post earnings per share of ₩1,585 for next year compared to ₩1,582 last year. Valuation Update With 7 Day Price Move • Nov 12
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₩17,810, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 10x in the Personal Products industry in South Korea. Total loss to shareholders of 11% over the past three years. Valuation Update With 7 Day Price Move • Oct 28
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₩21,850, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 11x in the Personal Products industry in South Korea. Total loss to shareholders of 1.7% over the past three years. New Risk • Jun 12
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Price Target Changed • Feb 19
Price target increased by 7.2% to ₩42,000 Up from ₩39,167, the current price target is an average from 6 analysts. New target price is 38% above last closing price of ₩30,400. Stock is up 74% over the past year. The company is forecast to post earnings per share of ₩1,466 for next year compared to ₩584 last year. Anuncio • Feb 13
CLIO Cosmetics Co.,Ltd to Report Fiscal Year 2023 Results on Feb 15, 2024 CLIO Cosmetics Co.,Ltd announced that they will report fiscal year 2023 results on Feb 15, 2024 Upcoming Dividend • Dec 20
Upcoming dividend of ₩200 per share at 0.6% yield Eligible shareholders must have bought the stock before 27 December 2023. Payment date: 10 April 2024. Payout ratio is a comfortable 14% and this is well supported by cash flows. Trailing yield: 0.6%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.2%). Reported Earnings • Nov 19
Third quarter 2023 earnings released: EPS: ₩556 (vs ₩187 in 3Q 2022) Third quarter 2023 results: EPS: ₩556 (up from ₩187 in 3Q 2022). Revenue: ₩84.8b (up 25% from 3Q 2022). Net income: ₩9.89b (up 206% from 3Q 2022). Profit margin: 12% (up from 4.8% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth. Major Estimate Revision • Nov 12
Consensus EPS estimates increase by 23% The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate increased from ₩1,207 to ₩1,490. Revenue forecast steady at ₩331.2m. Net income forecast to grow 65% next year vs 78% growth forecast for Personal Products industry in South Korea. Consensus price target up from ₩31,000 to ₩34,800. Share price rose 15% to ₩30,850 over the past week. Valuation Update With 7 Day Price Move • Nov 09
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₩32,200, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 17x in the Personal Products industry in South Korea. Total returns to shareholders of 88% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩41,682 per share. Price Target Changed • Oct 19
Price target increased by 8.1% to ₩31,000 Up from ₩28,667, the current price target is an average from 5 analysts. New target price is 11% above last closing price of ₩28,000. Stock is up 111% over the past year. The company is forecast to post earnings per share of ₩1,207 for next year compared to ₩584 last year. Valuation Update With 7 Day Price Move • Sep 08
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₩25,950, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 16x in the Personal Products industry in South Korea. Total returns to shareholders of 50% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩39,744 per share. New Risk • Aug 11
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Valuation Update With 7 Day Price Move • Aug 10
Investor sentiment improves as stock rises 29% After last week's 29% share price gain to ₩23,400, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 17x in the Personal Products industry in South Korea. Total returns to shareholders of 30% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩39,866 per share. Price Target Changed • May 17
Price target increased by 10% to ₩29,000 Up from ₩26,333, the current price target is provided by 1 analyst. New target price is 29% above last closing price of ₩22,550. Stock is up 28% over the past year. The company is forecast to post earnings per share of ₩651 for next year compared to ₩584 last year. Upcoming Dividend • Dec 21
Upcoming dividend of ₩150 per share Eligible shareholders must have bought the stock before 28 December 2022. Payment date: 20 April 2023. Payout ratio is a comfortable 49% and this is well supported by cash flows. Trailing yield: 1.0%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (1.3%). Valuation Update With 7 Day Price Move • Dec 05
Investor sentiment improved over the past week After last week's 17% share price gain to ₩15,700, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total loss to shareholders of 17% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩28,987 per share. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 1 independent director (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Anuncio • Nov 15
CLIO Cosmetics Co.,Ltd to Report Q3, 2022 Results on Nov 16, 2022 CLIO Cosmetics Co.,Ltd announced that they will report Q3, 2022 results on Nov 16, 2022 Valuation Update With 7 Day Price Move • Sep 20
Investor sentiment improved over the past week After last week's 17% share price gain to ₩16,100, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 16x in the Personal Products industry in South Korea. Total loss to shareholders of 14% over the past three years. Price Target Changed • Jun 22
Price target decreased to ₩28,000 Down from ₩30,333, the current price target is an average from 3 analysts. New target price is 95% above last closing price of ₩14,350. Stock is down 42% over the past year. The company is forecast to post earnings per share of ₩749 for next year compared to ₩552 last year. Major Estimate Revision • May 20
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 EPS estimate fell from ₩824 to ₩737 per share. Revenue forecast steady at ₩262.5m. Net income forecast to grow 40% next year vs 22% growth forecast for Personal Products industry in South Korea. Consensus price target of ₩30,800 unchanged from last update. Share price fell 5.8% to ₩17,200 over the past week. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 1 independent director (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Feb 09
Investor sentiment improved over the past week After last week's 21% share price gain to ₩19,450, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 11x in the Personal Products industry in South Korea. Total returns to shareholders of 53% over the past three years. Upcoming Dividend • Dec 22
Upcoming dividend of ₩100.00 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 20 April 2022. Payout ratio is a comfortable 16% and this is well supported by cash flows. Trailing yield: 0.6%. Lower than top quartile of South Korean dividend payers (2.4%). Lower than average of industry peers (0.8%). Price Target Changed • Jun 01
Price target increased to ₩29,000 Up from ₩26,800, the current price target is an average from 5 analysts. New target price is 5.6% above last closing price of ₩27,450. Stock is up 28% over the past year. Valuation Update With 7 Day Price Move • May 31
Investor sentiment improved over the past week After last week's 24% share price gain to ₩27,500, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 19x in the Personal Products industry in South Korea. Total returns to shareholders of 6.7% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩24,905 per share. Price Target Changed • May 20
Price target increased to ₩26,800 Up from ₩25,000, the current price target is an average from 5 analysts. New target price is 17% above last closing price of ₩22,850. Stock is up 2.5% over the past year. Reported Earnings • Mar 21
Full year 2020 earnings released: EPS ₩576 (vs ₩177 in FY 2019) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: ₩218.2b (down 13% from FY 2019). Net income: ₩9.59b (up 226% from FY 2019). Profit margin: 4.4% (up from 1.2% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings. Anuncio • Feb 22
CLIO Cosmetics Co.,Ltd, Annual General Meeting, Mar 26, 2021 CLIO Cosmetics Co.,Ltd, Annual General Meeting, Mar 26, 2021, at 09:00 Korea Standard Time. Is New 90 Day High Low • Jan 22
New 90-day high: ₩21,900 The company is up 37% from its price of ₩16,000 on 23 October 2020. The South Korean market is up 32% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩11,375 per share. Major Estimate Revision • Jan 16
Analysts lower EPS estimates to ₩550 The 2020 consensus revenue estimate was lowered from ₩241.6m to ₩226.5m. Earning per share (EPS) estimate was also lowered from ₩634 to ₩550 for the same period. Net income is expected to grow by 197% next year compared to 51% growth forecast for the Personal Products industry in South Korea. The consensus price target increased from ₩25,000 to ₩25,500. Share price is up 11% to ₩21,200 over the past week. Is New 90 Day High Low • Jan 05
New 90-day high: ₩18,900 The company is up 15% from its price of ₩16,400 on 07 October 2020. The South Korean market is up 23% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Personal Products industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩4,974 per share. Upcoming Dividend • Dec 22
Upcoming Dividend of ₩220 Per Share Will be paid on the 21st of April to those who are registered shareholders by the 29th of December. The trailing yield of 1.3% is below the top quartile of South Korean dividend payers (2.6%), but it is higher than industry peers (0.6%). Is New 90 Day High Low • Oct 27
New 90-day low: ₩15,600 The company is down 12% from its price of ₩17,700 on 29 July 2020. The South Korean market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩12,051 per share. Is New 90 Day High Low • Sep 24
New 90-day low: ₩15,750 The company is down 11% from its price of ₩17,650 on 26 June 2020. The South Korean market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩12,112 per share. 
